ALNT vs ITRN

Allient Inc. (ALNT) exhibits a Piotroski F-Score of 4, indicating a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The stock trades at a premium to its Graham Number ($21.18) and intrinsic value ($33.04), reflecting strong growth expectations rather than undervaluation. Despite elevated valuation metrics—P/E of 55.66 and forward P/E of 20.19—earnings and revenue growth are robust, with YoY earnings up 110.1% and revenue up 17.5%. Insider selling in the last six months and a bearish technical trend temper the outlook, but consistent earnings beats and a strong analyst buy consensus support upside potential. Price trades at a 88.7% premium to fair value estimate ($33.04), limiting near-term upside from a valuation perspective.

ITRN exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet strength. While the current price of $53.54 is a significant premium over the Graham Number ($26.84), it remains well below the growth-based intrinsic value of $67.31. The company combines steady double-digit growth with a highly attractive 11.21% dividend yield and negligible debt (D/E 0.02). Despite a bearish technical trend score and weak insider sentiment, the fundamental data suggests a high-quality compounder with significant margin of safety in its health metrics.